<SEC-DOCUMENT>0001070081-20-000106.txt : 20200604
<SEC-HEADER>0001070081-20-000106.hdr.sgml : 20200604
<ACCEPTANCE-DATETIME>20200604160519
ACCESSION NUMBER:		0001070081-20-000106
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20200529
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200604
DATE AS OF CHANGE:		20200604

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PTC THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001070081
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				043416587
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35969
		FILM NUMBER:		20942975

	BUSINESS ADDRESS:	
		STREET 1:		100 CORPORATE COURT
		CITY:			SOUTH PLAINFIELD
		STATE:			NJ
		ZIP:			07080-2449
		BUSINESS PHONE:		9082227000

	MAIL ADDRESS:	
		STREET 1:		100 CORPORATE COURT
		CITY:			SOUTH PLAINFIELD
		STATE:			NJ
		ZIP:			07080-2449

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PTC THERAPEUTICS INC
		DATE OF NAME CHANGE:	19980909
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8k6120.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:7A7FA7F567C256F99617B0C1B3ADCAD7,x:c320d123db134768b5c99b2caa9b365c-->
<!-- Document created using Wdesk  -->
<!-- Copyright 2020 Workiva -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2019-01-31" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2019-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2019-01-31" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2019-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2011-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2019-01-31" xmlns:lea="http://fasb.org/dis/lea/2019-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2019-01-31" xmlns:guar="http://fasb.org/dis/guar/2019-01-31" xmlns:ru="http://fasb.org/dis/ru/2019-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:leas="http://fasb.org/dis/leas/2019-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2019-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2019-01-31" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2019-01-31" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2017-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:fs-insa="http://fasb.org/dis/fs-insa/2019-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:cce="http://fasb.org/dis/cce/2019-01-31" xmlns:inv="http://fasb.org/dis/inv/2019-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:srt-std="http://fasb.org/srt-std/2019-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2019-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2019-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2019-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2019-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2019-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2019-01-31" xmlns:ceclcalc3l="http://fasb.org/dis/ceclcalc3l/2019-01-31" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2019-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:re="http://fasb.org/dis/re/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2019-01-31" xmlns:invco="http://fasb.org/dis/invco/2019-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2019-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2019-01-31" xmlns:currency-ent-dep="http://xbrl.sec.gov/currency-ent-dep/2019-01-31" xmlns:aro="http://fasb.org/dis/aro/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2019-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:srt-all="http://fasb.org/srt-all/2019-01-31" xmlns:codification-part="http://fasb.org/codification-part/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:sec-re="http://fasb.org/dis/sec-re/2019-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2019-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2019-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2019-01-31" xmlns:equity="http://fasb.org/dis/equity/2019-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:se="http://fasb.org/dis/se/2019-01-31" xmlns:crcrb="http://fasb.org/dis/crcrb/2019-01-31" xmlns:edco="http://fasb.org/dis/edco/2019-01-31" xmlns:te="http://fasb.org/dis/te/2019-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2019-01-31" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2019-01-31" xmlns:hco="http://fasb.org/dis/hco/2019-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:dr="http://fasb.org/dis/dr/2019-01-31" xmlns:ero="http://fasb.org/dis/ero/2019-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2017-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2019-01-31" xmlns:cecl="http://fasb.org/dis/cecl/2019-01-31" xmlns:rpd="http://fasb.org/dis/rpd/2019-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2019-01-31" xmlns:ceclcalc2="http://fasb.org/dis/ceclcalc2/2019-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2019-01-31" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2019-01-31" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2019-01-31" xmlns:soi="http://fasb.org/stm/soi/2019-01-31" xmlns:diha="http://fasb.org/dis/diha/2019-01-31" xmlns:debt="http://fasb.org/dis/debt/2019-01-31" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2019-01-31" xmlns:bc="http://fasb.org/dis/bc/2019-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2011-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2019-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2019-01-31" xmlns:rd="http://fasb.org/dis/rd/2019-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2019-01-31" xmlns:eui="http://fasb.org/dis/eui/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ap="http://fasb.org/dis/ap/2019-01-31" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2019-01-31" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2019-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2019-01-31" xmlns:sr="http://fasb.org/dis/sr/2019-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2019-01-31" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2019-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2019-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2019-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2019-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2019-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2019-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2019-01-31" xmlns:oi="http://fasb.org/dis/oi/2019-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2019-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2019-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2019-01-31" xmlns:cc="http://fasb.org/dis/cc/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2019-01-31" xmlns:disops="http://fasb.org/dis/disops/2019-01-31" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:cn-part="http://fasb.org/cn-part/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2019-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2017-01-31" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2019-01-31" xmlns:rlnro="http://fasb.org/dis/rlnro/2019-01-31" xmlns:ts="http://fasb.org/dis/ts/2019-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2019-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2019-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2019-01-31" xmlns:ni="http://fasb.org/dis/ni/2019-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2019-01-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2019-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2019-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2019-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2019-01-31" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2019-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2019-01-31" xmlns:ir="http://fasb.org/dis/ir/2019-01-31" xmlns:sheci="http://fasb.org/stm/sheci/2019-01-31" xmlns:foct="http://fasb.org/dis/foct/2019-01-31" xmlns:soc="http://fasb.org/stm/soc/2019-01-31" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2019-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2019-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2019-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2017-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:con="http://fasb.org/dis/con/2019-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2011-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2019-01-31" xmlns:eps="http://fasb.org/dis/eps/2019-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:iago="http://fasb.org/dis/iago/2019-01-31" xmlns:pay="http://fasb.org/dis/pay/2019-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:ptct="http://www.ptcbio.com/20200529" xmlns:tin-part="http://fasb.org/tin-part/2019-01-31" xmlns:acec="http://fasb.org/dis/acec/2019-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2019-01-31" xmlns:nt="http://fasb.org/dis/nt/2019-01-31" xmlns:spc="http://fasb.org/stm/spc/2019-01-31" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2019-01-31" xmlns:ides="http://fasb.org/dis/ides/2019-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2019-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2011-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:regop="http://fasb.org/dis/regop/2019-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2019-01-31" xmlns:com="http://fasb.org/stm/com/2019-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2019-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2019-01-31" xmlns:exch-ent-dep="http://xbrl.sec.gov/exch-ent-dep/2019-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ei="http://fasb.org/dis/ei/2019-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
	<head>
		<meta http-equiv="Content-Type" content="text/html" />
		<title>Document</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="D2020Q2CNSA" name="dei:AmendmentFlag" id="Fact-7118DE52C63753AAB1754B2219AE06A0-wk-Fact-7118DE52C63753AAB1754B2219AE06A0" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric contextRef="D2020Q2CNSA" name="dei:EntityCentralIndexKey" id="Fact-18BC15A005255D3C80F7EC4C756C33E4-wk-Fact-18BC15A005255D3C80F7EC4C756C33E4">0001070081</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="ptct-20200529.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="D2020Q2CNSA">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001070081</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-05-29</xbrli:startDate>
			<xbrli:endDate>2020-05-29</xbrli:endDate>
		</xbrli:period>
	</xbrli:context></ix:resources></ix:header></div><div><a id="s2481CFF27E0F5D30AE6FB442D0AE6792"></a></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">WASHINGTON, D.C. 20549</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM </span><span><ix:nonNumeric id="d204753e69-wk-Fact-B2A12A60057C5ABAB59A68A1A837D985" name="dei:DocumentType" contextRef="D2020Q2CNSA"><span style="font-size:18pt;font-weight:bold;">8-K</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:18pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">CURRENT REPORT</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Date of Report (Date of earliest event reported):  </span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d204753e83-wk-Fact-310D34A10D135EDAB5BF75C9EFB15CDE" name="dei:DocumentPeriodEndDate" contextRef="D2020Q2CNSA" format="ixt:datemonthdayyearen">May 29, 2020</ix:nonNumeric></span></span></span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:18pt;"><span><ix:nonNumeric id="d204753e86-wk-Fact-9725F84FACE45E9081AFB2326269AEF4" name="dei:EntityRegistrantName" contextRef="D2020Q2CNSA"><span style="font-size:18pt;font-weight:bold;">PTC THERAPEUTICS, INC.</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:18pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Exact Name of Company as Specified in Charter)</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:677px;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:214px;"></td><td style="width:16px;"></td><td style="width:214px;"></td><td style="width:16px;"></td><td style="width:214px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d204753e110-wk-Fact-602EDAC6CA985EF1A9F94FD6FFBBC18D" name="dei:EntityIncorporationStateCountryCode" contextRef="D2020Q2CNSA" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d204753e120-wk-Fact-3D4FE770794555E59F62D442807C4CCD" name="dei:EntityFileNumber" contextRef="D2020Q2CNSA">001-35969</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d204753e130-wk-Fact-10EBE69066D65325970B5FFB397D2B45" name="dei:EntityTaxIdentificationNumber" contextRef="D2020Q2CNSA">04-3416587</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(State or Other Jurisdiction</span></div><div style="padding-bottom:2px;padding-top:2px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">of Incorporation)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Commission</span></div><div style="padding-bottom:2px;padding-top:2px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">File Number)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(IRS Employer</span></div><div style="padding-bottom:2px;padding-top:2px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Identification No.)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:517px;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:141px;"></td><td style="width:114px;"></td><td style="width:33px;"></td><td style="width:228px;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d204753e182-wk-Fact-CEAEC0B57E5C576C9C5359AA252FD103" name="dei:EntityAddressAddressLine1" contextRef="D2020Q2CNSA">100 Corporate Court</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d204753e203-wk-Fact-13455C56901957C5BBED2C018AB98B57" name="dei:EntityAddressCityOrTown" contextRef="D2020Q2CNSA">South Plainfield,</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d204753e208-wk-Fact-42A7758705FD578F87AD0CB7F2B99AC5" name="dei:EntityAddressStateOrProvince" contextRef="D2020Q2CNSA">NJ</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d204753e218-wk-Fact-38E6159D05495CA185626C51FAF4922E" name="dei:EntityAddressPostalZipCode" contextRef="D2020Q2CNSA">07080</ix:nonNumeric></span></span></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Address of Principal Executive Offices)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Zip Code)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Registrant&#8217;s telephone number, including area code: </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d204753e245-wk-Fact-3251D880BB3F5A0299DA88555A3C0566" name="dei:CityAreaCode" contextRef="D2020Q2CNSA">(908)</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span><span><ix:nonNumeric id="d204753e249-wk-Fact-FE5012E9CBCC57E7BFF300C4EEE025ED" name="dei:LocalPhoneNumber" contextRef="D2020Q2CNSA"><span style="font-weight:bold;">222-7000</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Not applicable</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">see</span><span style="font-family:inherit;font-size:10pt;"> General Instruction A.2. below):</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span><ix:nonNumeric id="d204753e270-wk-Fact-37F7AC2E67E55CA9B226ECA5B8ED2BE4" name="dei:WrittenCommunications" contextRef="D2020Q2CNSA" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:5pt;">    </span><span style="font-family:inherit;font-size:10pt;"> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span><ix:nonNumeric id="d204753e280-wk-Fact-B3507459CBBC5F89A549806480E6AE05" name="dei:SolicitingMaterial" contextRef="D2020Q2CNSA" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:5pt;">    </span><span style="font-family:inherit;font-size:10pt;"> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span><ix:nonNumeric id="d204753e290-wk-Fact-5ADDBF28144652CFBA83096464BBAE3D" name="dei:PreCommencementTenderOffer" contextRef="D2020Q2CNSA" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:5pt;">    </span><span style="font-family:inherit;font-size:10pt;"> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span><ix:nonNumeric id="d204753e300-wk-Fact-68AAB5A98DF75493B86C8EAFB3853F5E" name="dei:PreCommencementIssuerTenderOffer" contextRef="D2020Q2CNSA" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:5pt;">    </span><span style="font-family:inherit;font-size:10pt;"> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:18%;"></td><td style="width:41%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Title of each class</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Trading Symbol(s)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Name of each exchange on which registered</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d204753e342-wk-Fact-42CBE19BEBDC51CD8811D227942318DF" name="dei:Security12bTitle" contextRef="D2020Q2CNSA">Common Stock, $0.001 par value per share</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d204753e347-wk-Fact-CE3323EC328D5B89B0A87D9E5141D921" name="dei:TradingSymbol" contextRef="D2020Q2CNSA">PTCT</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d204753e352-wk-Fact-63F94932548B575EB9FCFFDAB32DFBA6" name="dei:SecurityExchangeName" contextRef="D2020Q2CNSA" format="ixt-sec:exchnameen">Nasdaq Global Select Market</ix:nonNumeric></span></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Emerging growth company&#160;&#160;&#160;&#160;</span><span><ix:nonNumeric id="d204753e362-wk-Fact-4F3540726DB3505CA3525978EC84C2AC" name="dei:EntityEmergingGrowthCompany" contextRef="D2020Q2CNSA" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;  </span><span style="font-family:Wingdings;font-size:10pt;">o</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s6263E17B8D23519998B619ED0E9F3811"></a></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Introductory Note.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On May 29,&#160;2020, PTC Therapeutics, Inc. (the &#8220;Company&#8221;) completed the previously announced acquisition of Censa Pharmaceuticals, Inc. (&#8220;Censa&#8221;), a Delaware corporation (the &#8220;Merger&#8221;). The Merger was effected pursuant to an agreement and plan of merger, dated as of May 5, 2020 (the &#8220;Merger Agreement&#8221;), by and among the Company, Hydro Merger Sub, Inc., a Delaware corporation and a wholly owned, indirect subsidiary of the Company (&#8220;Merger Sub&#8221;), and, solely in its capacity as the representative, agent and attorney-in-fact of the securityholders of Censa, Shareholder Representative Services LLC, a Colorado limited liability company.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 1.01 Entry into a Material Definitive Agreement.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As a result of the Merger, the Company became a party to a license agreement dated as of February 8, 2015, as amended (the &#8220;License Agreement&#8221;) between Shiratori Pharmaceutical Co., Ltd. (&#8220;Shiratori&#8221;) and Censa. Pursuant to the License Agreement, Shiratori granted to Censa the sole and exclusive worldwide right and license, with the right to sublicense, under certain licensed know-how (the &#8220;Licensed Know-How&#8221;) and licensed patents (the &#8220;Licensed Patents&#8221;) relating to manufacturing processes and technology for sepiapterin, to research, have researched, develop, have developed, use, import, export, market, have marketed, offer for sale, sell and have sold, and otherwise commercialize any final pharmaceutical product in finished form containing sepiapterin as an active pharmaceutical ingredient (the &#8220;Product&#8221;) covered by the Licensed Patents or using the Licensed Know-How in all countries and territories of the world outside of Japan (the &#8220;Territory&#8221;). Shiratori is also responsible for supplying sepiapterin to the Company for manufacturing pre-clinical and clinical supplies of the Product.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Under the License Agreement, the Company is obligated to pay to Shiratori a low single digit percentage of annual net sales of the Product in each country in the Territory until the expiration of the last-to-expire Licensed Patent controlled by Shiratori covering the relevant country.  The Company is also obligated to pay to Shiratori certain regulatory and development milestones.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unless earlier terminated, the License Agreement will continue in full force and effect on a country-by-country and Product-by-Product basis until the obligation to pay royalties with respect to the sale of such Product in such country expires.  The parties may agree to mutually terminate the License Agreement. Shiratori may elect to terminate the License Agreement upon sixty days&#8217; prior written notice to the Company in the event that the Company fails to (i) achieve regulatory approval for the Product in either the United States or European Union by February 8, 2026 or (ii) commercially launch the Product in the United States or European Union by February 8, 2027.  The Company may elect to terminate the License Agreement upon sixty days&#8217; prior written notice to Shiratori.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The foregoing description of the License Agreement is a summary only and is qualified in its entirety by reference to the terms of the License Agreement, a copy of which will be filed with the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2020.</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 3.02. Unregistered Sales of Equity Securities.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The description of the common stock consideration under the terms of the Merger Agreement set forth in Item 8.01 is incorporated herein by reference. In connection with the closing of the Merger, the Company issued to the Censa securityholders the common stock consideration, and if the $30 million initial development milestone payment becomes payable and the Company elects to pay such payment in shares of its common stock, the Company will issue such shares of common stock to Censa securityholders in connection therewith, pursuant to an exemption from registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and/or Regulation D promulgated thereunder.</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 7.01. Regulation FD Disclosure.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On June 1, 2020, the Company issued a press release in which it announced the closing of the Merger. A copy of the press release is attached to this Current Report on Form 8-K (this &#8220;Report&#8221;) as Exhibit 99.1 and is incorporated by reference into this Item 7.01.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The information set forth in or incorporated by reference into this Item 7.01, including Exhibit 99.1, shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 8.01. Other Events.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On May 29, 2020, the Company completed the previously announced acquisition of Censa pursuant to the Merger Agreement. The Merger Agreement provided for the acquisition of Censa by the Company through the merger of Merger Sub into Censa, with Censa surviving as a wholly owned, indirect subsidiary of the Company.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Upon the closing of the Merger, the Company paid to the Censa securityholders total upfront consideration of approximately $50 million. The total upfront consideration was composed of (i) approximately $10.0 million, funded with cash on hand, subject to certain other pre- and post-closing adjustments, and (ii) 845,365 shares of the Company&#8217;s common stock. As previously disclosed, and subject to the terms and conditions of the Merger Agreement, Censa securityholders may become entitled to receive contingent payments from the Company based on the achievement of certain development, regulatory and net sales milestones as well as based upon a percentage of net sales of PTC923 (formerly known as CNSA-001) and sublicense fees paid to the Company in consideration of any sublicense of Censa&#8217;s intellectual property&#160;to commercialize PTC923.  Pursuant to the Merger Agreement, the Company has the option to pay the initial $30 million development milestone, if achieved, in cash or shares of the Company&#8217;s common stock.  </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The above description of the Merger Agreement is a summary only and is qualified in its entirety by reference to the terms of the Merger Agreement. A copy of the Merger Agreement was previously filed as Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K filed on May 6, 2020. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The representations, warranties and covenants contained in the Merger Agreement were made only for the purposes of the Merger Agreement, were made as of specific dates, were made solely for the benefit of the parties to the Merger Agreement and may not have been intended to be statements of fact but, rather, as a method of allocating risk and governing the contractual rights and relationships among the parties thereto.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01. </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Statements and Exhibits.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(d) Exhibits</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:95.8984375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:17%;"></td><td style="width:6%;"></td><td style="width:77%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit No.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">99.1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="censaclosingpressrelea.htm"><span style="font-family:inherit;font-size:10pt;">Press Release, dated June 1, 2020, issued by PTC Therapeutics,&#160;Inc.</span></a></div><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">104</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The cover page from this Current Report on Form 8-K, formatted in Inline XBRL</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cautionary Statement Concerning Forward Looking Statements</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">This Report contains forward-looking statements addressing the Merger and the other transactions contemplated in the Merger Agreement and any other statements about future expectations, prospects, estimates and other matters that are dependent upon future events or developments. All statements, other than those of historical fact, contained in this Report are forward-looking statements, including statements related to the potential financial impact and benefits to the Company of the Merger, including with respect to the business of Censa and the Company&#8217;s expectations with respect to contingent payments to the Censa securityholders based on net sales and sublicense fees and the potential achievement of development, regulatory and sales milestones and contingent payments to the Censa securityholders with respect thereto; the future expectations, plans and prospects for the Company; the Company&#8217;s strategy, future operations, future financial position, future revenues or projected costs; the integration of Censa&#8217;s operations; and the objectives of management.&#160; Other forward-looking statements may be identified by the words &#8220;look forward&#8221;, &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;target,&#8221; &#8220;potential,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;continue,&#8221; and similar expressions.&#160; The Company&#8217;s actual results, performance or achievements could differ materially from those expressed or implied by forward-looking statements it makes as a result of a variety of risks and uncertainties, including those related to: the Company&#8217;s ability to realize the anticipated benefits of the Merger, including the possibility that the expected benefits from the Merger will not be realized or will not be realized within the expected time period; significant transaction costs; unknown liabilities; the risk of litigation and/or regulatory actions related to the Merger; other business effects, including the effects of industry, market, economic, political or regulatory conditions; changes in tax and other laws, regulations, rates and policies; the eligible patient base and commercial potential of CNSA-001; and the factors discussed in the &#8220;Risk Factors&#8221; section of the Company&#8217;s most recent Quarterly Report on Form&#160;10-Q and Annual Report on Form&#160;10-K as well as any updates to these risk factors filed from time to time in the Company&#8217;s other filings with the SEC.&#160;As with any pharmaceutical under development, there are significant risks in the development, regulatory approval and commercialization of new products. There are no guarantees that any product or product candidate will receive or maintain regulatory approval in any territory, or prove to be commercially successful.&#160; The forward-</span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">looking statements contained herein represent the Company&#8217;s views only as of the date of this Report and the Company does not undertake or plan to update or revise any such forward-looking statements to reflect actual results or changes in plans, prospects, assumptions, estimates or projections, or other circumstances occurring after the date of this Report except as required by law. All website addresses given in this Report or incorporated herein by reference are for information only and are not intended to be an active link or to incorporate any website information into this Report.</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Signature</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:56%;"></td><td style="width:6%;"></td><td style="width:38%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">PTC Therapeutics, Inc.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Date: June 4, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">By:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">/s/ Mark Boulding</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Name:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Mark Boulding</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Title:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Executive Vice President and Chief Legal Officer</span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div>	</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>censaclosingpressrelea.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sF2FB62505EBAE3B4B816707DCE641D06"></a></div><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 99.1</font></div><div style="line-height:120%;text-align:left;"><img src="censaclosingpressrele.gif" alt="censaclosingpressrele.gif" style="height:68px;width:112px;"></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">PTC Therapeutics Successfully Completes Acquisition of Censa Pharmaceuticals</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">SOUTH PLAINFIELD, N.J., June 1, 2020</font><font style="font-family:Arial;font-size:10pt;">&#32;&#8211; PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it has successfully completed the acquisition of Censa Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of CNSA-001 (sepiapterin), a clinical-stage investigational therapy for orphan metabolic diseases, including phenylketonuria (PKU) and other diseases associated with defects in the tetrahydrobiopterin (BH4) biochemical pathways diagnosed at birth. </font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">"We&#8217;re thrilled to complete the acquisition of Censa,&#8221; said Stuart W. Peltz, Ph.D., Chief Executive Officer, PTC Therapeutics, Inc. &#8220;This acquisition adds a well established late-stage PKU clinical program to our growing rare disease portfolio. Given PTC&#8217;s established development and commercial capabilities, we&#8217;re well-positioned to bring this therapy to patients with unmet medical need expeditiously.&#8221;</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">With the acquisition, PTC adds CNSA-001 to its robust pipeline of treatments for rare disorders. CNSA-001 has been pursued as a possible treatment for orphan metabolic diseases associated with defects in the tetrahydrobiopterin biochemical pathways. CNSA-001 is an oral formulation of synthetic sepiapterin, a precursor to intracellular tetrahydrobiopterin, which is a critical enzymatic cofactor involved in the metabolism and synthesis of numerous metabolic products. The Phase 2 trial evaluating CNSA-001 for PKU met its primary and secondary endpoints in December 2019</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">1</sup></font><font style="font-family:Arial;font-size:10pt;">, and the program is Phase 3 ready. </font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">____________________________________________________________________________</font></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">1 - Bratkovic</font><font style="font-family:Arial;font-size:8pt;color:#333333;">&#32;</font><font style="font-family:Arial;font-size:8pt;background-color:#ffffff;color:#333333;">et al., A Phase 2 Randomized, Double Crossover, Open-label, Active Controlled Study Of CNSA-001 In Patients With Phenylketonuria, American College of Medical Genetics and Genomics (ACMG) Annual Meeting 2020.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">About Phenylketonuria (PKU)</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Phenylketonuria (PKU) is an inborn error of metabolism caused predominantly by mutations in the phenylalanine hydroxylase (PAH) gene resulting in toxic buildup of the amino acid phenylalanine (Phe) in the brain. Gene mutations of PAH result in inefficient Phe metabolism leading to hyperphenylalaninemia. There are at least 1,000 unique mutations in the PAH gene, resulting in phenotypic variation in the amount of enzyme produced and/or enzyme activity. With the near universal adoption of newborn screening for high plasma phenylalanine PKU is typically diagnosed at birth. PKU has been described in all ethnic groups, and its incidence worldwide varies widely, but is estimated that there are 16,500 patients in the U.S. If left untreated, severe and irreversible disability can occur to include permanent intellectual disability, seizures, delayed development, behavioral problems, and possibly psychiatric disorders. It has been shown that administration of tetrahydrobiopterin improves the function of PAH resulting in reduction in phenylalanine plasma concentration. CNSA-001 has the potential to address the metabolic and neurological signs and symptoms of a broad range of PKU patients.</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">About PTC Therapeutics, Inc.</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission  to provide access to best-in-class treatments for patients who have an unmet medical need. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, on Twitter at @PTCBio, and on LinkedIn.</font></div><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">For More Information:</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Investors:</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Alex Kane</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">+1 (908) 912-9643</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">akane@ptcbio.com</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Media: </font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Jane Baj</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">+1 (908) 912-9167 </font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">jbaj@ptcbio.com </font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Forward-Looking&#160;Statements:</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements, other than those of historical fact, contained in this release are forward-looking statements, including statements related to the potential financial impact and benefits to PTC of its acquisition of Censa, including with respect to the business of Censa and PTC's expectations with respect to contingent payments to the Censa securityholders based on net sales and sublicense fees and the potential achievement of development, regulatory and sales milestones and contingent payments to the Censa securityholders with respect thereto; the future expectations, plans and prospects for PTC; PTC's strategy, future operations, future financial position, future revenues or projected costs; the integration of Censa's operations; and the objectives of management.  Other forward-looking statements may be identified by the words "look forward", "plan," "anticipate," "believe," "estimate," "expect," "intend," "may," "target," "potential," "will," "would," "could," "should," "continue," and similar expressions. </font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">PTC's actual results, performance or achievements could differ materially from those expressed or implied by forward-looking statements it makes as a result of a variety of risks and uncertainties, including those related to: PTC's ability to realize the anticipated benefits of the acquisition, including the possibility that the expected benefits from the acquisition will not be realized or will not be realized within the expected time period; significant transaction costs; unknown liabilities; the risk of litigation and/or regulatory actions related to the acquisition; other business effects, including the effects of industry, market, economic, political or regulatory conditions; changes in tax and other laws, regulations, rates and policies; the eligible patient base and commercial potential of CNSA-001; the integration of Censa's operations and the factors discussed in the "Risk Factors" section of PTC's most recent Quarterly Report on Form 10-Q and Annual Report on Form 10-K as well as any updates to these risk factors filed from time to time in PTC's other filings with the SEC.  </font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">As with any pharmaceutical under development, there are significant risks in the development, regulatory approval and commercialization of new products. There are no guarantees that any product or product candidate will receive or maintain regulatory approval in any territory, or prove to be commercially successful.</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The forward-looking statements contained herein represent PTC's views only as of the date of this press release and PTC does not undertake or plan to update or revise any such forward-looking statements to reflect actual results or changes in plans, prospects, assumptions, estimates or projections, or other circumstances occurring after the date of this press release except as required by law.</font></div><div><br></div><div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ptct-20200529.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ptcbio.com/20200529" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ptct="http://www.ptcbio.com/20200529" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ptct-20200529_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ptct-20200529_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ptct-20200529_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ptct-20200529_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="CoverPageDocument" roleURI="http://www.ptcbio.com/role/CoverPageDocument">
        <link:definition>0001000 - Document - Cover Page Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="ptct_CoverpageAbstract" name="CoverpageAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>ptct-20200529_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.ptcbio.com/role/CoverPageDocument" xlink:href="ptct-20200529.xsd#CoverPageDocument" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.ptcbio.com/role/CoverPageDocument" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>ptct-20200529_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.ptcbio.com/role/CoverPageDocument" xlink:href="ptct-20200529.xsd#CoverPageDocument" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.ptcbio.com/role/CoverPageDocument" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>ptct-20200529_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_ptct_CoverpageAbstract_9F9EA1EE689BFAAE34CB12EB78562B6C_label_en-US" xlink:label="lab_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">cover page [Abstract]</link:label>
    <link:label id="lab_ptct_CoverpageAbstract_9F9EA1EE689BFAAE34CB12EB78562B6C_documentation_en-US" xlink:label="lab_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">cover page [Abstract]</link:label>
    <link:loc xlink:href="ptct-20200529.xsd#ptct_CoverpageAbstract" xlink:label="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="lab_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_C4517B94B84052FE32B512EB785B4079_terseLabel_en-US" xlink:label="lab_dei_DocumentType_B7297C399CEB5C628B99EFCF0C377200" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_C4517B94B84052FE32B512EB785B4079_label_en-US" xlink:label="lab_dei_DocumentType_B7297C399CEB5C628B99EFCF0C377200" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_B7297C399CEB5C628B99EFCF0C377200" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_B7297C399CEB5C628B99EFCF0C377200" xlink:to="lab_dei_DocumentType_B7297C399CEB5C628B99EFCF0C377200" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_0E83231B49EC1FE81A3612EB785BBF36_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_02EBA1A69AFF5040922C9B52AC75F112" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_0E83231B49EC1FE81A3612EB785BBF36_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_02EBA1A69AFF5040922C9B52AC75F112" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_02EBA1A69AFF5040922C9B52AC75F112" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_02EBA1A69AFF5040922C9B52AC75F112" xlink:to="lab_dei_DocumentPeriodEndDate_02EBA1A69AFF5040922C9B52AC75F112" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_C596222BA97ACDF1A10B12EB785B6491_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_F355CC6D6D155F11A0B87A44E4DC74A2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_C596222BA97ACDF1A10B12EB785B6491_label_en-US" xlink:label="lab_dei_EntityRegistrantName_F355CC6D6D155F11A0B87A44E4DC74A2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_F355CC6D6D155F11A0B87A44E4DC74A2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_F355CC6D6D155F11A0B87A44E4DC74A2" xlink:to="lab_dei_EntityRegistrantName_F355CC6D6D155F11A0B87A44E4DC74A2" xlink:type="arc" />
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_F7E76C8EB6B2A429763012EB785A74D9_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_DBE2669DF300555E94C348E351C65FF9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_F7E76C8EB6B2A429763012EB785A74D9_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_DBE2669DF300555E94C348E351C65FF9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_DBE2669DF300555E94C348E351C65FF9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_DBE2669DF300555E94C348E351C65FF9" xlink:to="lab_dei_EntityIncorporationStateCountryCode_DBE2669DF300555E94C348E351C65FF9" xlink:type="arc" />
    <link:label id="lab_dei_EntityFileNumber_E7EA6DB36C0F561D720212EB7B8131CB_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber_185536D04EF35D41A21DD0E3616C8AF3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contained File Information, File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_E7EA6DB36C0F561D720212EB7B8131CB_label_en-US" xlink:label="lab_dei_EntityFileNumber_185536D04EF35D41A21DD0E3616C8AF3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_185536D04EF35D41A21DD0E3616C8AF3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_185536D04EF35D41A21DD0E3616C8AF3" xlink:to="lab_dei_EntityFileNumber_185536D04EF35D41A21DD0E3616C8AF3" xlink:type="arc" />
    <link:label id="lab_dei_EntityTaxIdentificationNumber_E3123AAC3A41E48A1A9712EB785C4170_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_4FC6D8C502E050CE9CD050713F75D8EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_E3123AAC3A41E48A1A9712EB785C4170_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_4FC6D8C502E050CE9CD050713F75D8EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_4FC6D8C502E050CE9CD050713F75D8EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_4FC6D8C502E050CE9CD050713F75D8EC" xlink:to="lab_dei_EntityTaxIdentificationNumber_4FC6D8C502E050CE9CD050713F75D8EC" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressAddressLine1_DDE7C637B1DE93E587D112EB785A5F77_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_8E882D6444835579A7BF57371F5ADE18" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_DDE7C637B1DE93E587D112EB785A5F77_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_8E882D6444835579A7BF57371F5ADE18" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_8E882D6444835579A7BF57371F5ADE18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_8E882D6444835579A7BF57371F5ADE18" xlink:to="lab_dei_EntityAddressAddressLine1_8E882D6444835579A7BF57371F5ADE18" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCityOrTown_592048EF44AAE536846012EB785C0C8F_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_DED9FE99822E5FDFA90F2B26AD45FA08" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_592048EF44AAE536846012EB785C0C8F_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_DED9FE99822E5FDFA90F2B26AD45FA08" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_DED9FE99822E5FDFA90F2B26AD45FA08" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_DED9FE99822E5FDFA90F2B26AD45FA08" xlink:to="lab_dei_EntityAddressCityOrTown_DED9FE99822E5FDFA90F2B26AD45FA08" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressStateOrProvince_D134AAF98F8970CE5DA412EB785C86A7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_E7CA518B452E5D9C932E90BE23EC6DEB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_D134AAF98F8970CE5DA412EB785C86A7_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_E7CA518B452E5D9C932E90BE23EC6DEB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_E7CA518B452E5D9C932E90BE23EC6DEB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince_E7CA518B452E5D9C932E90BE23EC6DEB" xlink:to="lab_dei_EntityAddressStateOrProvince_E7CA518B452E5D9C932E90BE23EC6DEB" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressPostalZipCode_3A88E27A4B92A3EB914412EB785C141A_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_C6E4E5BD316F5A009E650739DB238E37" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_3A88E27A4B92A3EB914412EB785C141A_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_C6E4E5BD316F5A009E650739DB238E37" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_C6E4E5BD316F5A009E650739DB238E37" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_C6E4E5BD316F5A009E650739DB238E37" xlink:to="lab_dei_EntityAddressPostalZipCode_C6E4E5BD316F5A009E650739DB238E37" xlink:type="arc" />
    <link:label id="lab_dei_CityAreaCode_1AEC18E92172051E527C12EB785C731C_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode_9F06EFBF38C156AFA52B2BFF26466C82" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_1AEC18E92172051E527C12EB785C731C_label_en-US" xlink:label="lab_dei_CityAreaCode_9F06EFBF38C156AFA52B2BFF26466C82" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_9F06EFBF38C156AFA52B2BFF26466C82" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_9F06EFBF38C156AFA52B2BFF26466C82" xlink:to="lab_dei_CityAreaCode_9F06EFBF38C156AFA52B2BFF26466C82" xlink:type="arc" />
    <link:label id="lab_dei_LocalPhoneNumber_5A3B1F056BEACDAA3FC312EB785D41F0_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber_DBAA27A3CC055B23A9C9890C244AFC9E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_5A3B1F056BEACDAA3FC312EB785D41F0_label_en-US" xlink:label="lab_dei_LocalPhoneNumber_DBAA27A3CC055B23A9C9890C244AFC9E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_DBAA27A3CC055B23A9C9890C244AFC9E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_DBAA27A3CC055B23A9C9890C244AFC9E" xlink:to="lab_dei_LocalPhoneNumber_DBAA27A3CC055B23A9C9890C244AFC9E" xlink:type="arc" />
    <link:label id="lab_dei_WrittenCommunications_DCE23CB8DE201B588EA312EB785DBCD6_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications_BCC8EACBD67657709C27420C60D1ACA5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_DCE23CB8DE201B588EA312EB785DBCD6_label_en-US" xlink:label="lab_dei_WrittenCommunications_BCC8EACBD67657709C27420C60D1ACA5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_BCC8EACBD67657709C27420C60D1ACA5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications_BCC8EACBD67657709C27420C60D1ACA5" xlink:to="lab_dei_WrittenCommunications_BCC8EACBD67657709C27420C60D1ACA5" xlink:type="arc" />
    <link:label id="lab_dei_SolicitingMaterial_760B757C59FA279516CD12EB785D2D23_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial_65802183AA8D560DAA74DA2945ED467D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_760B757C59FA279516CD12EB785D2D23_label_en-US" xlink:label="lab_dei_SolicitingMaterial_65802183AA8D560DAA74DA2945ED467D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_65802183AA8D560DAA74DA2945ED467D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial_65802183AA8D560DAA74DA2945ED467D" xlink:to="lab_dei_SolicitingMaterial_65802183AA8D560DAA74DA2945ED467D" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementTenderOffer_344CB19EC791150E96E912EB785DB49A_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_7A20210DB3935750B63BB3359B832ED3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_344CB19EC791150E96E912EB785DB49A_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_7A20210DB3935750B63BB3359B832ED3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_7A20210DB3935750B63BB3359B832ED3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer_7A20210DB3935750B63BB3359B832ED3" xlink:to="lab_dei_PreCommencementTenderOffer_7A20210DB3935750B63BB3359B832ED3" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_59137A62338E67AAB28C12EB785D6654_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_4AAE5F95D90658D1994189ACA4AD34AA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_59137A62338E67AAB28C12EB785D6654_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_4AAE5F95D90658D1994189ACA4AD34AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_4AAE5F95D90658D1994189ACA4AD34AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer_4AAE5F95D90658D1994189ACA4AD34AA" xlink:to="lab_dei_PreCommencementIssuerTenderOffer_4AAE5F95D90658D1994189ACA4AD34AA" xlink:type="arc" />
    <link:label id="lab_dei_Security12bTitle_001777A8A6AF6538D2A412EB7859C521_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle_908BE89FD04455E0B2C435220573AD55" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_001777A8A6AF6538D2A412EB7859C521_label_en-US" xlink:label="lab_dei_Security12bTitle_908BE89FD04455E0B2C435220573AD55" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_908BE89FD04455E0B2C435220573AD55" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_908BE89FD04455E0B2C435220573AD55" xlink:to="lab_dei_Security12bTitle_908BE89FD04455E0B2C435220573AD55" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_B80EC5FA2E5A9146AE5012EB785D4F73_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_0ECC99EEDF515FC0AD140BE8439841F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_B80EC5FA2E5A9146AE5012EB785D4F73_label_en-US" xlink:label="lab_dei_TradingSymbol_0ECC99EEDF515FC0AD140BE8439841F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_0ECC99EEDF515FC0AD140BE8439841F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_0ECC99EEDF515FC0AD140BE8439841F7" xlink:to="lab_dei_TradingSymbol_0ECC99EEDF515FC0AD140BE8439841F7" xlink:type="arc" />
    <link:label id="lab_dei_SecurityExchangeName_BD2611354DB294EA551E12EB785E1FBF_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName_BDA1CC966137583695DA1E1CC5CC4361" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_BD2611354DB294EA551E12EB785E1FBF_label_en-US" xlink:label="lab_dei_SecurityExchangeName_BDA1CC966137583695DA1E1CC5CC4361" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_BDA1CC966137583695DA1E1CC5CC4361" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_BDA1CC966137583695DA1E1CC5CC4361" xlink:to="lab_dei_SecurityExchangeName_BDA1CC966137583695DA1E1CC5CC4361" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_273F49BF87E829DB473712EB785EE2F6_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_C56ADCF6D68552A9A363338CA6F3AE62" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_273F49BF87E829DB473712EB785EE2F6_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_C56ADCF6D68552A9A363338CA6F3AE62" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_C56ADCF6D68552A9A363338CA6F3AE62" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_C56ADCF6D68552A9A363338CA6F3AE62" xlink:to="lab_dei_EntityEmergingGrowthCompany_C56ADCF6D68552A9A363338CA6F3AE62" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_FB2DC3B7252F22BA459212EB785B3EDD_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_D61804A23F495396BE5F6DAAD006ABE4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_FB2DC3B7252F22BA459212EB785B3EDD_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_D61804A23F495396BE5F6DAAD006ABE4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_D61804A23F495396BE5F6DAAD006ABE4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_D61804A23F495396BE5F6DAAD006ABE4" xlink:to="lab_dei_EntityCentralIndexKey_D61804A23F495396BE5F6DAAD006ABE4" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_32233D09D70BAE14723212EB785B60EE_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_397CD30762E256F3B4A5F40D7AB9DF80" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_32233D09D70BAE14723212EB785B60EE_label_en-US" xlink:label="lab_dei_AmendmentFlag_397CD30762E256F3B4A5F40D7AB9DF80" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_397CD30762E256F3B4A5F40D7AB9DF80" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_397CD30762E256F3B4A5F40D7AB9DF80" xlink:to="lab_dei_AmendmentFlag_397CD30762E256F3B4A5F40D7AB9DF80" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>ptct-20200529_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.ptcbio.com/role/CoverPageDocument" xlink:href="ptct-20200529.xsd#CoverPageDocument" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.ptcbio.com/role/CoverPageDocument" xlink:type="extended">
    <link:loc xlink:href="ptct-20200529.xsd#ptct_CoverpageAbstract" xlink:label="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_B7297C399CEB5C628B99EFCF0C377200" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_DocumentType_B7297C399CEB5C628B99EFCF0C377200" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_02EBA1A69AFF5040922C9B52AC75F112" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_DocumentPeriodEndDate_02EBA1A69AFF5040922C9B52AC75F112" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_F355CC6D6D155F11A0B87A44E4DC74A2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_EntityRegistrantName_F355CC6D6D155F11A0B87A44E4DC74A2" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_DBE2669DF300555E94C348E351C65FF9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_EntityIncorporationStateCountryCode_DBE2669DF300555E94C348E351C65FF9" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_185536D04EF35D41A21DD0E3616C8AF3" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_EntityFileNumber_185536D04EF35D41A21DD0E3616C8AF3" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_4FC6D8C502E050CE9CD050713F75D8EC" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_EntityTaxIdentificationNumber_4FC6D8C502E050CE9CD050713F75D8EC" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_8E882D6444835579A7BF57371F5ADE18" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_EntityAddressAddressLine1_8E882D6444835579A7BF57371F5ADE18" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_DED9FE99822E5FDFA90F2B26AD45FA08" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_EntityAddressCityOrTown_DED9FE99822E5FDFA90F2B26AD45FA08" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_E7CA518B452E5D9C932E90BE23EC6DEB" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_EntityAddressStateOrProvince_E7CA518B452E5D9C932E90BE23EC6DEB" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_C6E4E5BD316F5A009E650739DB238E37" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_EntityAddressPostalZipCode_C6E4E5BD316F5A009E650739DB238E37" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_9F06EFBF38C156AFA52B2BFF26466C82" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_CityAreaCode_9F06EFBF38C156AFA52B2BFF26466C82" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_DBAA27A3CC055B23A9C9890C244AFC9E" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_LocalPhoneNumber_DBAA27A3CC055B23A9C9890C244AFC9E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_BCC8EACBD67657709C27420C60D1ACA5" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_WrittenCommunications_BCC8EACBD67657709C27420C60D1ACA5" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_65802183AA8D560DAA74DA2945ED467D" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_SolicitingMaterial_65802183AA8D560DAA74DA2945ED467D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_7A20210DB3935750B63BB3359B832ED3" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_PreCommencementTenderOffer_7A20210DB3935750B63BB3359B832ED3" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_4AAE5F95D90658D1994189ACA4AD34AA" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_4AAE5F95D90658D1994189ACA4AD34AA" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_908BE89FD04455E0B2C435220573AD55" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_Security12bTitle_908BE89FD04455E0B2C435220573AD55" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_0ECC99EEDF515FC0AD140BE8439841F7" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_TradingSymbol_0ECC99EEDF515FC0AD140BE8439841F7" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_BDA1CC966137583695DA1E1CC5CC4361" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_SecurityExchangeName_BDA1CC966137583695DA1E1CC5CC4361" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_C56ADCF6D68552A9A363338CA6F3AE62" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_EntityEmergingGrowthCompany_C56ADCF6D68552A9A363338CA6F3AE62" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_D61804A23F495396BE5F6DAAD006ABE4" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_EntityCentralIndexKey_D61804A23F495396BE5F6DAAD006ABE4" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_397CD30762E256F3B4A5F40D7AB9DF80" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_F27466AD8E2B579FAA7A2BF325D4EEB3" xlink:to="loc_dei_AmendmentFlag_397CD30762E256F3B4A5F40D7AB9DF80" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>censaclosingpressrele.gif
<TEXT>
begin 644 censaclosingpressrele.gif
M1TE&.#EA= 52 _8      $$Z7^E-.>I..>I/.>M0.NM1.NM2.NM3.NM4.NM4
M.^M5.^M6.^M7/.M8/.M9/.M9/>Q:/>Q;/>U</>U=/>U>/NU?/NU@/NUA/^UB
M/^UC/^UD0.UE0.UF0>UG0>YG0>YH0>YH0NYI0NYJ0N]K0^]L0^]M1.]N1.]O
M1.]O1>]P1>]Q1?!R1?!R1O!S1O!T1O!U1_!V1_!W2/!X2/!Y2/%Y2?%Z2?%[
M2?%[2O%\2O)\2O)]2O)]2_)^2_)_2_)_3/* 3/*!3/*!3?*"3?*#3?*$3O.%
M3O.&3_.'3_2'3_2'4/2(4/2)4/2*4?2+4O2,4O2-4_2.4_6/5/605?:15?:2
M5?:25O:35O:45O:45_:55_:65_:66/:76/:86/>86?>96?>:6?>:6O>;6OB;
M6OB<6_B=6_B>7/B?7?B@7?BA7@
M                                                 "'Y! $
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MYHE5R$RF,I<Y&&^ZDYOCC*<\YTG/>MKSGO@<)Q/VR?]/?I8S?NQ\23K5N<Z
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M$2S!$ES!'P1"%HS!(23"(G3!+T#")%3")61")60G&KPW\RL\-.LB';RN()Q
M(]3"+02#)O3"+P1#+Q##,23#,C3#,R3#=8+"_SB[,XWS/RNR0NP:0C"DPSK\
M C3$PSS4PSWT@B[PPS\$Q$ 4Q"Y0IS6<CI=S0QRL(@_T+CYTQ$?$PT&4Q$FD
M1"ZPQ$O$Q$S4Q$VT1'0R1)FIO9-[0]IK0_3*0TI$Q53L DYDQ5;<Q"V Q5B4
MQ5F,12VPQ5O$Q5S$Q7/Z1'0+18X;12DJQ?3Z0U<T1E>DQ62415UDQF9TQF>$
MQF<TIUY,-E?3(VH,LV%,+V6<Q6CTQF\$1W#,@G$DQW(TQW-$1W,LIX=#N3W"
MQBB40O4*QWEDQG2TQWM,1RS0QWWDQW[4QRL R( 4R($D2( D)W9<-3]ZQQ31
MQO?"QX>\1W^4R'XLR/^*M,B+Q,B,+,AQ0DA0"Z2%3)QX=*^)_$>--,F31,F+
MM(*59,F6=,F5K(*8E,F9I$F:%*>.U#I! DDV%$GW2LF?#,B7%,J6K,FB-,JC
MG$DJ4,JE9,JF=$JG#"><1#Q"VLE8:\CW&DJA1,JMY,HJ>,JO!,NPG(*Q),NR
M-,NS1,NS!">I!$!%JLKQ8$3Z,LJPI,NZI(*TQ,N\U,N]G (I\,N_!,S %$R_
M7$NV?,O#4\0:BDOX4DJ^=,S'Q,O!E,S)I,S*M,S!_";#)#-*.LQ?L\']VLO+
M%,W1)$W*C(+31,W45,W59,W6C )OTLPKRZ3./,2KA*_2Q,W =,W=Y,W>=$W_
M* #.X!3.X23.X83-V"2R3Z+-0/M,_?+-YX3.WRS.Z:3.ZK3.ZZ3.;D).&S.E
MY61.[^2KW<3.\23/\C1/ZWR"]%3/]63/]M3.[12Q5P+/%K)-]SK/^SS/]M3/
M_>1/]G2"_P30 !70 250;H)/!].E^6RV^E0O\NS/!X70)R#0":70"G6")L#0
M#-70#>70#N50 SW0-#LF!5W0GE0O_K30%+50#V71%G71%X71%P71 ^7(8%3,
M.'PO (W1'>71'O51#F6"(!72(272(C52)IA1*BPI$BU1$R6O'X72%CW2*:52
M(UV"*\72+-72+>72+MTF)OT^&W6QMG0O#ZW2,SW3_RY5TS5ETS9= B6 TSB5
MTSF%TR2PTSNUTR\5TXT"TR9UTNX*4C<5U$%=4SHU5#G%TT15U$5EU$9M5#U-
M3(_JTP%JOO02U$/%5$?5U$WEU$1%@D\%U5 5U4\]@E(UU5-%552%5"4EJ4FE
MU$H=KTZ554X=U5H-U53%U5S5U5,U@E[UU5\%UF %UE4EO"7=4U*$5>ZZ4UME
MUEUUUF<] F&5UFFEUB*PUFO%UFS5UFW%5F+=3&.-U U,5NN"UFBEUG-%5VY5
MUW5EUW9U5W7UUC';M&,MN,^[+FE]UWS5UWWEUVPE@G\%V( 5V($=V'@5LWD-
MUQQTM.CJUX;-5X*%V(B5V/\AH-B*M=B+Q=B,O5B#5;=6I5<XE+3E>E>))=F2
M)0*-1=F45=F5I5@A<-F7A=F8E5F.]3*$9=4QLK3@BEB6Y=F>15F9!=J@%=J8
M#8*B-=JC1=JD1=HD+5:/3=@J3#K8\EF+'=JJM5HA4-JLU=JMY5JE!8*O!=NP
M%5NF_5:GO5G$C%K,NEJ7[=JV==NV%=NXE=NYG=L?L-N[Q=N\M5L?X%L?(%MY
M!=>S;3M2@ZRWY5JZ1=S$%5N]95R\[=O'A=S(E=S)I5R__=N##=RF7:.&@RO%
MI=O&!=T?J-S1)=W2-=W)[8'45=W59=WW?-IB^UC.R[6J.MW:M=W;Y5O6U=W=
MY5W_WN6!WP7>X!7>W]V!XCW.U\TH5\U B5-.3<)=RNW=Z)7>U1W>Z@W>XL7>
M[-7>[>5>[M6![P5?\#U>P04IY=V_96LD,M&DZ95>ZW7?[H7?^/7>\*7?^M6!
M',#?_-7?_>7?_LW?S(Q=BS+?6RDW/-(U3>(!^55@^;7?!OY>_X7@");@"<X!
M'+#@"\;@#+;@&^!@ $;>:0O@S0TX+J*A3G+@\*7@%%9A"-;@%L9@#H;A&);A
M&:9A&K:!&\;A&R[,#[ZH 1Z8$+TTGMRP3UIA%G9A%Z[A)%9B&\[A)G;B)X9B
M'*Z!*:;B*J;BJ SA<,OBG0/B7_2D"U[B,%[B*";C,LYA_RM&XS168S6F@39V
MXS>&XS?&8AX6X"V&N2YFT$PRXSU^XC7VXS^NXC@6Y$$FY$(V9!J8@416Y)NT
MXXCR80O"8_+E)$"FY"D^Y$O&Y$-6Y$WFY$[VY$].9!D0Y5$F91FH43JNJ$=&
MUDA^LE+*Y%<>9%"6Y5G>Y%*VY5O&Y5S695L^R$9N,%_F(U9.SE*BY6(&Y5U&
MYF169E&.@69VYF>&YFB6YFENYG4$9GZ[YC\29C SI67VYF6FYG 6YW$FYW(>
MB["P9E368G5>I&V.3U2ZY7*6YWFF9VD^YWO&YWS69W1.9TF6U&QV2W=.LE2J
MYWK>YX-&Z(-^@85FZ(9VZ(>&Z/^'K@UD0E)2*=N14N4V$N@L0Z6$]NB/_HJ(
M%NF1AFC<,.F31FG;:(&59NF5-J8E2!-_[JB,GJ.-9K55RF>2UFF=3NF>]FD7
M:.F@%NJA)NJB)NIB2H(M >B%HNEKM&D,"B6'_NFI/FFCMNJKQNJ@)I"MYNJN
M+I!ARM-6TUR1:FJ=?&HH2B6@SNJU9FNA]NJWAFL6.)*YINNZMNN[%B93U9FE
MMCB^ED\@?J6LCNO!WNJ[-NS#1NR[9I+%9NS&5H%@\M49&NM4\^L$94=8ZNK$
MUNS-5FS']NS/5I(4$.W1)NW2-NW3)NU?ZE8&(R_.U27.IFO0EFW'1NW:MNW3
MMI3<UNW_W9847UIMU@9N[.FQ:9KMT+[MX[9MWE;NY69N%-"6YX;NZ([N7A+8
MX+;NCD+NYM;N[984Z?;N[P9O<!'O\1YO7MK8ZT9OC.+NW ;O]G;O$R#O^);O
M^8YOD;%OD=&EEGW9].9OBWIO[Z;O !=P\K[O C?P R\!N5'PDM&EI.WO!Y>H
M 9=P$T#P"D?P!<?P#-?P#<<EI87P#W<H"Q?QD=GP$C?Q$T?QDZF;%6=Q7)I;
M$(=QA4KQ&:?Q$V?Q&\?Q',]QW^%Q'K^ER8WQ(#>H&C=Q'3?R(V?Q'E?R)6=R
MXG'R)_]QR17R*1<H)+=R'6?R+-?RW7GR+O?R+P?S$("@!JJE_]ZE\C/WIRU7
M\]X)\S9W\RX?\SB7\SFGH#JO(%J*7S37\WQZ\S[_\CD']$ ' 3LG]$(W= KR
M@$17]$5G]$2O)?O]WSV7='H:'D&W]#@_]$S7] ]H]$Y?] X ]5 7]5$G]5(G
M=0Y =52G)0F>]%:'IT'?]%@G=$^G=5.W]5LO]537]5WG]5[W=0[8@& 7=F&G
MI25V]6-G)UIO=%QG=ES_]6>'=ET?]FFG]FJW]FNW=EHR8V2'\,;9Z_ A)&>/
M]G'W=6PW]W-']W17=VRG)4K&N ZKQA\C(7 ?G$>+MS+[S@..Z0*+H8'V&PZJ
M'1/BL'^3=[PI8<G6-DCJ]75G^(9W>/]UUX"(E_B)I_B*MWB+QPE:NF3D@W<1
M&J'E03:0-[!X\?=M.[=]][5ZZR^2+W@F@NK#2?EX#WF"Y^A^K_E#>OB<1_>+
MY_F>Q_B< /J@%_JA)_J;H"5C_N&._Y?J*2% ^W>G%^L546H/NW=^KWKU]7A$
M6_HA=CAZNWIFL^B5-Z1U]_FR]_FB1_NT5WN@#XJV=_N=H*5EQJ(\ZQ2 ;WIZ
MWS6O%VYO9YLLF?KH.;"L5R&X[!FZW_N6#WN][WK%#WB^EY[I.?D^,ONUI_S*
M#_JWQWS,QXS-7XI9RN5HUB+#/_R9A_F/EWG&?U4.<GR7QS>;)_W2Q_JM?WF$
M?_W'K_W3C_W_OY]]D4=]V^]]UO_]>A]\/;)\HL_\XP<*SE?^Y5\*SIB*6I+G
M#MQ]F@]^WS=]P1<XJV1ZT5>.Z9=]Q'^AZP?^ZH\=NQ=]X1]^E+]].'D>QQ=X
M[U<CY$]^YJ=_^G?^^]^,T=!_SZ@ECR9AO <(  ('$A08X"#"A H1%FSHT.#"
MB P?4GPH\6* BAHW<J2(46)'AQ\7ABP)8.3$DR@SF@RY,F'+@B]3EIQY,";.
MFC9QVF29DV//GR:#"B5(=.A.H4F+,FWJ]"E4 !>F4JUJ]2I6K!:V<NWJ]2O8
MKQ7&DBUK]BQ:M!36LFWK]NW;J'+GTJW+% ;>O'KUONAK]V_3I76/_R)]&5@P
MX(Z$"Z^<:WC@XZB+6TX&BCCQQLJ69_[5+-=S3- >+U,FC?DT:KEA5[/VFO8U
M[+1P9].N;?OMA-RZ=^].[?LW<(U]AQ-_X>(X\N/!E\ODW-ET9N=%1?^F;A'Z
MS\@043K&OEF[2^_5Q5^73M?Z8?/3R3-7B;X]_-.QYYN];?^^?=[Z]_/G+^$_
M@ $*"&!\!1H857(NM+ @@PTR>"!P["DE87/@Y?3>:1@:1:%BC35D(5,:5@CB
M=QX:*.)V)#Z%(D\<:L3B>#W=!"&-=>%WHVW]Z;@C;P/Z^".000HI8(U%&KF1
M@TDJR<*1&:K7G8Q1FCBAE#)^YJ*54#V9XO]'DKG(I8HO5IFEEE^Z%V9Z:*YH
M9GEJ'CBF3TW*V5%;/-JIXY!YZKFGGA'X^2>@@0H:Z)R%'LD"HHDJFN@*C3IJ
MZ'-NK@<GI3"%6*FDC$WY(9Q0CC3:II.J66EVF(9ZZ98E<F<7C*6EVN*K35(*
M*:03\'DKKK@.NBNOO?HJ* 3!"CMLL+0::Z"CR2J[;*/'GA>K4Z9BFJ:T%UU9
M+9E>K@KJIVMB*Z6HWY*D;:8CGEHFM-Z6&UVZLL[J+(2YYODKO?7^2BR^^#ZP
M+[_]^OLOP/[".S!P*AA\,,()*TPPN=L.)BZXJ$*LT+436\OJJ.?":G&7T7)L
M*;KK0L9F>.U2ZW#_N"@3_"[#OMG[LKWYRAQLP#7;#+ #.>N\,\\]^]QS T&W
M/'1B*1A]--))&XT"TTP3?7+'&)O,J<AM:AS<Q^,"YN;4[&8]HZ=71VAFJQUV
M3675W(H]<*=/T\7KS#+?//?-/]M]M\]!Z[TWWWW[[3<#@0ON-N%S-7TXXHD?
M7CC:*E>\MM7=IBQY@:"17#+E8D*N:N80EAVVXYQ'_>S9I99>T>=SCLDX4W37
MC#?L>/\].^V "WX[[KGKOCOO#+#^>U$G"#\\\<4;+SSP&X<>\N94-Z]YVE)G
M'+WH64,].HVI-[P\],\KSSWSX&LJOML1)]]1[$#7OC[MO;O_/ORX+S ___WU
MVW\__O.?OW]+)OC_/P #*$#_\6]\V -=Y\SF/;61+S76N1P#OT:3"T$P4M0C
M7=JTA[H**G"!&SR=!A_7P-^Q3V_Q.R$*<Y>_%;(0?PIX(0QC*,,9TG"&!;SA
M1DJ@PQWRL(<^Y"$..YC [0W1:R/LWA$Q@QX.FDN"(*/@Z5 30H]%<8HB8:(1
MDXC$(G[P@EN+(L-2"+\6DK&%-3PC&FF8@#6RL8UN7","XBC'.=*1CJ:KTH8B
MXBJ*!3$D)/@C( ,IR$$&LH_5 XD%/7@F+4:.BV.;&A87Z40^0M&+B63D)1T9
MP0,2D9,(].3W-'E%,$H2E(?48P'+6,8TLC*-;_]\91OK*,M9TI*.![@E+G.I
MRUW>\F$3W"38LOA$0U*$D,8\YA^)N46,?+&*I,RC)3O)3,PITGFB;.3%*EE-
M)4:2BHJTHC4Q&1HLHJA5,.IFD5J)1EBRLY;N?"<">"G/>=+S  :X)S[SJ<]]
MZK.9P>SB32C)+2XILR(D& %"$ZK0A3)4H04%Z#4;ATD.@G-RIL1F-K49T5&*
MLY07;4]%+?K1)FY4HR6]XS8YZKW/94N((R48&^$I4UG6LZ;UY"=.<ZK3G?*S
M #[]*5!_RLU?1FYD_X0F-./TT(&(H*E.?2I4HQK5I6(4D=+[YC.-.DF![M&#
MEWLFFT+JS:T2U8 DPJ/_/U.JDZR&,U7F$ZGCT,HXF]*5ESR]*UYY&M2]\K6O
M?B4 8 ,KV,$2P('#9."(G&<NJ@XD!(Y]+&0C*]G),E:E)QVG,Z-)5JUA-H-D
MRRH8Q7J]28[6>D.-YBE1*<V/B5""K,LK;&/KU]G2-JB$O2UN<RO8 ?"VM[[]
MK6\?>=2B+O9,*JUL9$&@W.4RM[G.76YEVSK-JTZ4K1XEK4E?:MF35O"SUO7E
M9H>+4H[Y1K1)[6AJI956B[U6I[5][U]U*]_Y$@"X]KTO?O.KW]\RAZN(W:Y2
MM1I@8GZ@P 8^,((3K. "1Y>DTP4O5C4;WK*Z5+L ?K P,3Q>"PL8O>LE*X2G
M_[4<\W;XLME='=;4^[OXTK?%@]TOC&,LXQG/6  VOO&-X>-?XAY7;0W^,9"#
M+.0A$_E212Z<>"&5Y",SN<E.?C*4HRSE*5.YRE:^,I:SK.4M<[G+7OXRF,,L
MYC&3N<QF/C.:TZSF-;.YS6Y^,YSC+.<YT[G.=KXSGO.LYSWSN<]^_C.@ RWH
M01.ZT(8^-*(3K>A%,[K1CGXTI",MZ4E3NM*6OC2F,ZWI37.ZTY[^-*A#+>I1
MD[K4ICXUJE.MZE6SNM6N?C6L8RWK6=.ZUK:^-:YSK>M=\[K7OOXUL(,M[&$3
MN]C&/C:RDZWL93.[V<Y^-K2C+>UI4[O:UKXVMK.M[?]M<[O;WOXVN,,M[G&3
MN]SF/C>ZTZWN=;.[W>Y^-[SC+>]YT[O>]KXWOO.M[WWSN]_^_C?  R[P@1.\
MX 8_.,(3KO"%,[SA#G\XQ",N\8E3O.(6OSC&,Z[QC7.\XQ[_.,A#+O*1D[SD
M)C\YRE.N\I6SO.4N?SG,8R[SF=.\YC:_.<YSKO.=\[SG/O\YT(,N]*$3O>A&
M/SK2DZ[TI3.]Z4Y_.M2C+O6I4[WJ5K\ZUK.N]:USO>M>_SK8PR[VL9.][&8_
M.]K3KO:UL[WM;G\[W.,N][G3O>YVOSO>\Z[WO?.][W[_.^ #+_C!$[[PAC\\
MXA.O^,4SOO&.?SSD(R_YR5/_OO*6OSSF,Z_YS7.^\Y[_/.A#/VDUD+[TIC\]
MZE.O^M6SOO6N)[WH8R_UU].^]K:_/>YSKWLUR+[W(-\]\(,O_.$3O_BE]SWR
M]6W\Y3._^<Y_/NZ3+WUM0[_ZUK\^]K.O^NESO]?:_S[XPR_^[W>__*,>/_K3
MK_[U7]_\[E<T^^,O__G3W_GOO_^<Z[_[T^B___X//OX%8)?%7Y#]GP&RGP F
MX)!I'YL=H -6GP)&X W9'_P]H 4"GP1F(+P47ZE=H ?2G@:&8($ H*Y]H FB
MG@BFH%U$'[2=H FJ( R:A.V-FPM>8 S>X.O56PT>X T*8.L5W [Z7P\BW^I5
M7!#6_]\0:M[VC=P1RE\2.AX*QEP3(N 3!I[I =T4JE\5UMT5+ET6HM\6JMWQ
M7=T7BE\8?AWLC5T9@M\9MN&^K2'YN:$<VAL<8M\<WB&]U6'[X2$?PIL>0F ?
M!B*[_2'T":(AIALA4N A+B*Y)6+S,2(DBILC+E\D5J*W3:+Q6:(F;ALF$M\F
M?N*U=:(G@B(I2ILH"E\IIN*SG2()JJ(K)ALK[M\KSN*QQ:+NT2(N$ILMYEXN
M]B*P[2(+^J(PEB PSN P'F-I39AJ95DQUAXR/N.%*2-Y.5DS@B TTJ(T9N-W
M$4XUYN U6J(VAF.U4%4WNI[)B2,ZIN-A,9DZMJ,[OJ,[8O\9/,ZCJ1A2.;(>
MR=&C/JIC@^VC/_XC0(H8E 4D0;+,^=PC/H)<02ZD-!(30SXD1!8D.T8D1:+8
M[R#D$G9<16XD=IT/1WXD2#8DD(4D2:(3C6!DZFED2:XDQ+ .2[XD3*H85<4D
M32YC\J!D%&9<3>ZD0#(,3_XD4%J50P9E3=HC3G:AQ1&E4K:4L2RE4Q9E$#TE
M5!+342+EQ$DE5JI5C&0E5VYD 75E3))C5::AQ(&E6=KDD9RE6BZD1Z[E2D;7
M6)+EP[DE70[8F]0E7L*C2^8E20)97/+>7/+E6A:)8!:F.):/88;D L:EPR7F
M8-ZE8T;F5@V-9'XDD_TEPU6F6E;_CF9VYC3"BV=Z)34R9L*%YEF"E&FFIDS2
MBFI2I)1AYL&U)EB.F&S6YENICFT^9)7!)L'E)E<*EV\&IX81IG"RY961YL 5
M)U:6EW(VYXYYCG,&Y)8A)\!%YU-*D74ZIY%D)T!Z&6_Z&W<ZY6F%IV_6"'GZ
M8YA]Y[Z=YU)^&'NJ)F2^YSR2&77JFWPJ)77=IVERIG[JI9G5Y[WU9U"&F(!V
MIHX5Z#NFF7K6&X("Y2<UJ&/2)H2V8P..9;Y-*$^V%H8:)G!NJ#:^V8+&FX?N
M9/B,J& RIXF&HYP!*+RE*$VJBXOR)7;&:#;268BV&XW"Y%CE*%V.)X]NUIW=
MJ+K]*$LF_R.19F5B'.F$Y9F0HIN2EJ3$/*E99I*4FI:>L6BZ5:EB2I26+B<&
M96>*]>2>-2FY=2E(<JF9BJ>&RB9KFJ2886FYI:EEGIB<#NAJ:2;C9!2@D2FX
MU2E'TJF?9BB,&FA4VJ6?\:FW3>6)%&8H!:J#[FB$KANB<INB;J=;-JJC"BI<
MX>6\36JV52INSF:4@>JH)B:^>>JUD:JA=&6IAB65<2B_H6JUJ6I37N= ONB4
MG2C R>JTT>JQV*J3^2J1<:K!\2JT">NOXN>3(>M(]JC"&:NS,6NRVFF326MT
M.2O#02NS6>NT:NI$NFJU;F;$::NR<6NWFNM2H6M!G:81PNFLXO_J[SSJM^KH
MO"(IQN%D&N1KOG:;NM8JB88KN XKJVY<(NJKP1XLPB9L&E JO */MQ99O^*0
MJ';<!2JLQ5XLQEKLMD6LOS:LP 9LL]KK[X5?QI:LR68L&J2LRJXLRZ:LMG%L
MF\*LQ'IL/XJLR 7?R>:LSNIKR_:LS_XLRYZ!T'XJS<:KS-[0T1JM5*(<Z>VL
MTYHLT$:MU**!T%:MU5XMUEXMMB5MH?SKD7$MDGDIRCTMRDZMV;9LUJ:MVJXM
MVYY!JA:MTM+KU\)MN@*KRF'LV>:MRK8MW_:MW_*MM8%MJ,HMQ-+MNJJIR^EM
MS_XMXS:NX_ZM&9C!NX)L\@ANY1KN4+;_)\RM[.-VKN=^;N2&KNB.+NF&+K59
MKKM0KI"AKD\B+LQ]+NQZ;NG.+NW6;AG<+N[F;J]B+N&P[EZJKC*YKLS%KNS6
MKO$>KQGDKO(N+_,V;QE(F^\2)_"&+.$^E/#.'/$BK_;.KO-VK_=^K_.20;1%
MKWGR;F61;\?*Z\U=[?:VK^B"+_S&;_B2 ?W6K_W>+QF,@?[J[[&:[].@+V).
M;Z$2Y<ZY;^3*+P(G<!G@+P/;[_X^, 1'L 2/P;,!\*(*\(]9\."J;\XIL =[
M;P.'\ 2/, F7\ 17L/]29@K/Y H[+ '[W <W;P@WL G7L V;L!CDL [O, ^+
M0;2V,-MH,-$(_W%:OC ,,^\,T_ -+S$3ZV\//_$.AX$43S$55W$5-QL1]U<6
MMRX&[X^R IT#-[$8VS 4E[$5GS$:IS$5@P$;MS$8;"L0.XO7UFN1'BX'_]P8
MWW 90[$:][$?AX$;![(@#W(@PW$7M\S#%NXAN_ =XS$9[W$/_[$DGS$A5[(E
M#_(79+(F;_(F+]L6HV@<6V\H_V\C QTD3S(J3_$EK_(E<[(KOS(LP[(7E.LH
M=VTB*W+USNQ/)ETJ4S(K_[(@Q[(P#_,F>X$Q'S,R)[,RSS*R?;*3S#' YC+2
MEG+0K3$P7S,;$[,VQ_(R=[,W?W,W)YLS)^DNW^HBYRDU"QTV;S,[<_\R.+\S
M/,>S%W0!/=>S/=-S,]>RI9:S.4LS_Z2ST+4S.\LS01?T,=\S0B>T0B?TL8WS
ME][RW)YS[P)T0'.S05\T/"^T1F^T/7.!1W\T2(<T2#>T/L<G1:]N28,F/R\=
M1K<T1[_T0HNT3,\T38?T%MST31N;0P_J2O?S2_81M3(=1L,T4=]S31\U4G,!
M3B\U4S>U%CPU5#^U3J>TA&INKE)U^F)US14U5W=!4G^U3#>U6"]U5)>U69\U
M6A?;3F-J4$O96G>H1 ?=2X,U77_T6-\U6N>U7N\U7VL!L;UU>AGQ5<>U"D.T
MTM5U3=_U6/<U8S>V8^]U%F3!7VMUB4ZIE0'_MF$9]F';M&([]6-_-F@S=F2/
M-FF7MFF/]K Y,YY>&6;/:&M_'$Z'MFS/MEF?MFW?-FYC@6[O]FZG=J829):]
MMH_Z<]/1MG%#-6XGMW)'-F\WMW/K]A5$MW1/MW0+VV]WIY8)MWO^--4==UDO
M-WC;]G./-W13MWF?-WJ;MW5?]SYRF793*7=/G5Z'-WV/-GF3=WKGMW[O]WX'
M&WOK8Y>]=W[&-]75MVG?]W/SMX(O.(/KMQ4\.(3[]W_[IWM3]@83=M'9-X(W
M=X-WN(<O.(2'N(B+>!64N(F?.+!->#Q^F8 3*(%/W8?'N(R;]XC7>(B?.([G
MN([O>(JK>#J&68L__V@=6]V,%_D5V#B2[[B2+[F.4X&3/SF41[F3_YJ/'Z:8
M!?F:#GG5&;ET([F-,SF8,[F4CSF9ESF43P&:4WF5U^B88?F=0NG5G;>7?WF8
MUWF.FSF>YSD5H#F?][F?_SF?J_F:AY>9N7EEOSC50;B=+_J)Z[FCCSF@1[JD
M3_JD^]J@ ^F9&3I/$S?4,7H5/#JH/SFECSJIE_H42 &JI[JJI[JE7[H3J9FF
M0RJG/UVH/[JIWSJN\_FJ[SJO]SJOM[JKL]::Q;J1]B76Y7FN)WNI^SJS-[NS
M.WNO!?MG#KN%IRXT4YVR9SN:/SNW=[NW,WL4A+NX1[NTBPN<$7N45OO.:?_[
MM[>[NW.[N,>[O,\[O4<!N9=[/<H9NF\JG&/=MK\[P >\JM<[P1>\P1,\K^$[
MJ=39OJ,IHE.=P$=\JA\\Q5?\P4,!QF>\QF\\%"2\PLL5PZO[/E\[Q$O\P%L\
MRJ=\N',\R[>\RW.\QW^\FV:WR$LOR4\=N*N\SE/\R_>\S_]\S^^:S&MEH==\
M^?8TU>V\T@,]TS>]TS.]T ^]GO99PV\8AA_=SC^]UF\]U[?\$WP]V(?]$T2]
MU%,8U1O]T=^\U'4]V[>]TXL]W,>]W(L]V<N\HE6]U3_\U+D]WP/]W/\]X(N]
M$PP^X1>^X0]^W0?[H^$]H+XEUO7]TP>^Y/_]X5?_ON5??N$W@>8W@:Y=>J4Q
M/EMK>=6Y_>27ON!C/NJGOA-L/NNWONN[?N?_]Z:!?F=IMM-MO.GG_A.H/N];
M_NO_/O '?_#'?IV*&NW7_O$WG.[O?N\W_^ +/_1'O_1//_$?Z:HEOUG->M,Y
M?_-/O_=_/_B'?_5/**YA_UHA?=2I?OBO/_NW/^LS ?S'O_S/O_R/O^C_F_E3
MD^TOG?OWO_^_/D P$3B08$&#!PTN4;@00$.'#R%&E#B18D6+%S%FU+B18T>/
M'S$&$#F29$F3)U&F5+F29<L (&'&E#F39DV;-W'FO.B29T^?/UGJ%'H3:%&C
M1WL.5;J4:5.G3Z%&;=J$_VI5JU>Q9M6ZE:M5A%_!'EPXEFQ9LTNDIE6[5BU2
MMV^+LI4[EVY=NP#@YM6[\B[4O7\!I^P[F'!APX>?=E6\N&I8QV'/1I8\^2QB
MRY>?!M:<%W-GSY\S;Q9]%'3-T:?AEE:]FG7KFXR]/I8MEG)MVY.5Y-:]F[=K
MW[_QHA;N$GAQXZ"')^=[7*-RY\291Y<^O>YLZP)O9]>^D'?W[DG AQ<_/CQU
M\WV?IQ]YGGU[INK5NX\(GWY)^??QY[?H>'O_V]X!S(V\ 0DLD$#]$!RJ/N<2
M;-!!B194+L$(ZWO0P@N!\T]#[@+TSL /00QQ/"1(+!$)#%'LB,+A4FS1O16%
MF_\0QO1<K-'&P394J$,/1>S1QQ%-#%)()(XHTL@C;TSRH1E/4]+)WY@<K<$H
M&7S2RBMU&FO'[W[LLL<AP23QR#')+--,+&ND<C,TV<1,3<VF?)/%-NFL$R,E
MO,P3Q##!--///\LT0M!!"2W4"#LOE!,P1!FM2]&_''P4M48IM5//#_D<$M!-
M 374TT]!);2((BJ54=+42DTUM%/?BI15T52--<D0,Q62TUL##57774?MU==?
M@1U5UOM>;7788W$JUJT'E843V6<=Y!/7:8W<U5I0@\U6VVVSA?:\9DGS5MR/
MP#6*V7(A'5==]JC-]=IW!^56WGGIE7?=Z- %ZMY]+<K_]R<+_=V+WX&!.Q+>
M@XVH5^&%&5:88. "3NKAB2/F*=&*C9U88\\0;MCCCT'NE8B122[9Y)$W;@WC
MEE(>>.6@+G[9W)9I+BSDFW'F]N2=>>[9Y"&&J+DTF542>EVB!8L9Z7^-;IJM
MG*'6V>>IJ28"Z*NQSEIKH)WN;.F3NO;V:Y-0'%O?L-%F*FJ%JVY[YZWACEON
MN--&S&R2ZC[V[O7*WMOBO &WZ6:W"2=Y[L,13QQH(1AOW'$A B?,[Y<B3W7R
M%B?_N_+-.?*U\,(5#UUTK!\OW?33'>?\KLM5;Y3UOC-GN?79*?I\]-L31UWW
MW1\/PO??@0\^"-KG>IWX-HW'_S!VS8^?'??GX^9=>MV%K][ZZX5O?JWDM;>2
M>Z677Z[[S:&'>_KS>\=>_?79#QZ(]]\?7ZKOY;^1?H##AZ[^O.5&WW\AVA=
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M[_-R'_WM18]ZW>^>]ROP_>^!K_HD+*7UKC<M[-$F^\C23NNX=_[B>1]]Z;,
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M&(\)^>@7C6<)*=N+*9(5W9&C3:B=A4X&M6&44H;689567HFEATIN>>2)7IH
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0J(5;R(5=Z(5?"(:$%Q  .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>9
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "a8k6120.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "ptct-20200529_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ptct-20200529_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "a8k6120.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ptct-20200529_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ptct-20200529_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "ptct-20200529.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd",
      "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ptct",
   "nsuri": "http://www.ptcbio.com/20200529",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a8k6120.htm",
      "contextRef": "D2020Q2CNSA",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001000 - Document - Cover Page Document",
     "role": "http://www.ptcbio.com/role/CoverPageDocument",
     "shortName": "Cover Page Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a8k6120.htm",
      "contextRef": "D2020Q2CNSA",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Contained File Information, File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "ptct_CoverpageAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "cover page [Abstract]",
        "label": "cover page [Abstract]"
       }
      }
     },
     "localname": "CoverpageAbstract",
     "nsuri": "http://www.ptcbio.com/20200529",
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>a8k6120_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ptct-20200529.xsd" xlink:type="simple"/>
    <context id="D2020Q2CNSA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001070081</identifier>
        </entity>
        <period>
            <startDate>2020-05-29</startDate>
            <endDate>2020-05-29</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="D2020Q2CNSA"
      id="Fact-7118DE52C63753AAB1754B2219AE06A0-wk-Fact-7118DE52C63753AAB1754B2219AE06A0">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="D2020Q2CNSA"
      id="Fact-18BC15A005255D3C80F7EC4C756C33E4-wk-Fact-18BC15A005255D3C80F7EC4C756C33E4">0001070081</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="D2020Q2CNSA"
      id="d204753e69-wk-Fact-B2A12A60057C5ABAB59A68A1A837D985">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="D2020Q2CNSA"
      id="d204753e83-wk-Fact-310D34A10D135EDAB5BF75C9EFB15CDE">2020-05-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="D2020Q2CNSA"
      id="d204753e86-wk-Fact-9725F84FACE45E9081AFB2326269AEF4">PTC THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="D2020Q2CNSA"
      id="d204753e110-wk-Fact-602EDAC6CA985EF1A9F94FD6FFBBC18D">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="D2020Q2CNSA"
      id="d204753e120-wk-Fact-3D4FE770794555E59F62D442807C4CCD">001-35969</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="D2020Q2CNSA"
      id="d204753e130-wk-Fact-10EBE69066D65325970B5FFB397D2B45">04-3416587</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="D2020Q2CNSA"
      id="d204753e182-wk-Fact-CEAEC0B57E5C576C9C5359AA252FD103">100 Corporate Court</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="D2020Q2CNSA"
      id="d204753e203-wk-Fact-13455C56901957C5BBED2C018AB98B57">South Plainfield,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="D2020Q2CNSA"
      id="d204753e208-wk-Fact-42A7758705FD578F87AD0CB7F2B99AC5">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="D2020Q2CNSA"
      id="d204753e218-wk-Fact-38E6159D05495CA185626C51FAF4922E">07080</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="D2020Q2CNSA"
      id="d204753e245-wk-Fact-3251D880BB3F5A0299DA88555A3C0566">(908)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="D2020Q2CNSA"
      id="d204753e249-wk-Fact-FE5012E9CBCC57E7BFF300C4EEE025ED">222-7000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="D2020Q2CNSA"
      id="d204753e270-wk-Fact-37F7AC2E67E55CA9B226ECA5B8ED2BE4">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="D2020Q2CNSA"
      id="d204753e280-wk-Fact-B3507459CBBC5F89A549806480E6AE05">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="D2020Q2CNSA"
      id="d204753e290-wk-Fact-5ADDBF28144652CFBA83096464BBAE3D">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="D2020Q2CNSA"
      id="d204753e300-wk-Fact-68AAB5A98DF75493B86C8EAFB3853F5E">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="D2020Q2CNSA"
      id="d204753e342-wk-Fact-42CBE19BEBDC51CD8811D227942318DF">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="D2020Q2CNSA"
      id="d204753e347-wk-Fact-CE3323EC328D5B89B0A87D9E5141D921">PTCT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="D2020Q2CNSA"
      id="d204753e352-wk-Fact-63F94932548B575EB9FCFFDAB32DFBA6">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="D2020Q2CNSA"
      id="d204753e362-wk-Fact-4F3540726DB3505CA3525978EC84C2AC">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="a8k6120.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Cover Page Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ptcbio.com/role/CoverPageDocument</Role>
      <ShortName>Cover Page Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="a8k6120.htm">a8k6120.htm</File>
    <File>censaclosingpressrelea.htm</File>
    <File>ptct-20200529.xsd</File>
    <File>ptct-20200529_cal.xml</File>
    <File>ptct-20200529_def.xml</File>
    <File>ptct-20200529_lab.xml</File>
    <File>ptct-20200529_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M^L/O)NR"L0?[CXVO@K*%7W<AOP!02P,$%     @ J8#$4)E<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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ME.PC-7[\CKL<LV>PW^;@%H=/,;RSF]=V];I)B^3JPDR([8B !P2[(Q(;^RX
MI  ,].R!#C0](^G90,\?Z)FW/XS(:8&<%,@1?>8)8,2<%IB1 C-$7W@"&+&D
M!>:DP!S15YX 1K"45EB0"@O,9YX$ 0GD>4E*+#'?3S0!"61Z14JL,-]/-0$)
MY)JEM)U2',%/-X4)))P%3,O^FW("PE8!$=JX#% $0+6!P 2J Z/]S;!] 7P5
M I,%5&B3,^QAR'T5 C,+J-!.9]C(,/=5",PBH$+;G6$WP])7(3 A%=KR#!L:
MT!TC,"$5VO4,>SI#=PQC@BJT\1FV=>;7+PH3*&! 6Q^PK3._A%&80 T#VOJ
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MG.[V9ZC%H-[.!?>_1/$#4$L#!!0    ( *F Q%#;_<0U/0$  # "   /
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M<&?M(F+O_I5,XN\YAL^:_P!02P,$%     @ J8#$4/_ )@B]    A0(  !H
M  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<ZV200J#,!  OR)Y0%=MZ:&H
MIUZ\MOU T-6(FH3LENKOFWI10:$'+PEAP\Q DCRPD]P83:JQ% Q]IRD5BMG>
M *A0V$LZ&8O:3RKC>LG^Z&JPLFAEC1"'X17<DB&R9,D,\C(5+B\C$;RDJY%3
M 4,''^-:4HA,,&W1R0O\E='B/WI354V!=U.\>]2\43$+!&P'Q7,0*>FP?+)K
M=$U'AZS@>S'G10R/'1Y?,5'W])=9SUZ",*V'O\E$_37 ZM=E7U!+ P04
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MH%W\S<A'2NU!7PW_R?(+4$L! A0#%     @ J8#$4!\CSP/     $P(   L
M             ( !     %]R96QS+RYR96QS4$L! A0#%     @ J8#$4"?H
MAPZ"    L0   !               ( !Z0   &1O8U!R;W!S+V%P<"YX;6Q0
M2P$"% ,4    " "I@,107M:R*^\    K @  $0              @ &9 0
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "I@,10F5R<(Q &  "<)P
M$P              @ &W @  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( *F Q%"Z,3*OHP(  )<+   8              "  ?@(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "I@,10A@]V[F,"  #>!0
M%               @ '1"P  >&PO<VAA<F5D4W1R:6YG<RYX;6Q02P$"% ,4
M    " "I@,10NJ$YBM<!   R!@  #0              @ %F#@  >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( *F Q%#;_<0U/0$  # "   /
M  "  6@0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "I@,10_\ F"+T
M  "% @  &@              @ '2$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    " "I@,10"X_8 R$!  !7!   $P
M@ ''$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "@ * ( "   9%
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6638977024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page Document<br></strong></div></th>
<th class="th"><div>May 29, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ptct_CoverpageAbstract', window );"><strong>cover page [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 29,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PTC THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Address, State or Province</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Contained File Information, File Number</a></td>
<td class="text">001-35969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3416587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 Corporate Court<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South Plainfield,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(908)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">222-7000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PTCT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001070081<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ptct_CoverpageAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>cover page [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ptct_CoverpageAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ptct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001070081-20-000106-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001070081-20-000106-xbrl.zip
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MKQ&:G53R1]I34>3>M5M<V$-C6NB-"I7&C#6'"PU*>T<LG^:;=11HANYT:K&
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M/AU/NM84W->^BBT*F[3]$NZ>7X#RJKA<=D53CWXD/P<1> I@[05@[Y$W-/G
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M8MLI2 J[2'+#KPO*6] 4#K<BKUH1LCSB)-K2@ =/N:)%:87K2'F$Y(R$F.9
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M\FWJD.S>6";[(*GN#0^LQCOCGWP]$> Z>A02]ZYT/YVC->*.UF-ND0'T%P^
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M6!8.'1<ULH.X!@=C^'0T![,\06/V&:GW3U4W8!K&<Q<,V"U5 2U-W>&!_.[
M%TX<',J/$#];<%W]O.&A9<-V3[V0*$_T4XL'E3KZL=?GW^NAI':?RFR8@JUY
M+G+M/9%K/Y #?H:]3K;GW^_FSM(S_I0_F6 \%A8_-.+]D;A_]/[PIQZ^'LD^
M:?G1H_?^@Y:_+UKF/^GS'<O?V3TXUSR@\S_X/AB6M/$<IWAJ=NVS)7G-5C0@
M;Y=+Z) \51W-L\5G#B:8_)?BPR+RMJ_^^O)LG6V"5_\?4$L#!!0    ( *F
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MZ*1ORM[ F1FT@*!D%P.6&1P4;[J[!( K%SHKF!%:(!TKB#+O%I4DXIF=R"R
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MIO C<%+M )REC8\F8,$?(4VNR4MB3B(GI%FSI72O&?3>*1&-L$$0C@HH92G
M(\V9BI/GCKCPY-7AW"]V+X=ZGP]U"IT6@U:1S4Z%E;>J.1IG6LUIB@Y[RF7=
MXI7CS[<:JX3L16[A E1KV#D#"B^O54D-CTTI(J;@F>;7>+V*#\G*A75">Z(W
MT 31Z>1LQLK]%5#NTY&^IJI3QF[Q8!?IQCMT[("33Z9=UE1@#0S@XRXMGP7E
MV?Z_LH"ZSE0=R%I.H8JY"$Q0.NZ[K_!5.V'F/S;Z>I__"NK@GU!+ P04
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MZD9ZM_3[.IQ)?I2Q&X7??^%!_7\W.PM!YT"54$:I,;WY!Y/>)U!+ P04
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M V;$+R-XT/!?9.N3.<"07^7W\Z!7<&&'3LH<I,)8<RB0B"-MI3;P'F'J(@Z
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M4$L! A0#%     @ J8#$4)IA';FX"P  9&<  !4              ( !13L
M '!T8W0M,C R,# U,CE?;&%B+GAM;%!+ 0(4 Q0    ( *F Q%#26(FNG@8
M '4U   5              "  3!'  !P=&-T+3(P,C P-3(Y7W!R92YX;6Q0
52P4&      < !P#, 0   4X

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
